Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Hereditary High Risk Breast Cancer Panel Baylor Genetics United States | 34 | 7 |
|
Fulgent Genetics United States | 70 | 26 |
|
Ovarian Cancer Comprehensive Panel Fulgent Genetics United States | 39 | 18 |
|
Colorectal Cancer Comprehensive Panel Fulgent Genetics United States | 77 | 22 |
|
Gastric Cancer Comprehensive Panel Fulgent Genetics United States | 37 | 15 |
|
Breast Cancer Comprehensive Panel Fulgent Genetics United States | 52 | 20 |
|
Full Comprehensive Cancer Panel Fulgent Genetics United States | 329 | 127 |
|
Pancreatic Cancer Comprehensive Panel Fulgent Genetics United States | 55 | 22 |
|
Epilepsy Comprehensive NGS Panel Fulgent Genetics United States | 729 | 398 |
|
Fulgent Genetics United States | 33 | 15 |
|
Fulgent Genetics United States | 62 | 18 |
|
Fulgent Genetics United States | 40 | 14 |
|
Invitae United States | 138 | 80 |
|
Invitae Common Hereditary Cancers Panel (Breast, Gyn, GI) Invitae United States | 75 | 42 |
|
CeGaT GmbH Germany | 14 | 1 |
|
CeGaT GmbH Germany | 3 | 1 |
|
Asper Biogene Asper Biogene LLC Estonia | 135 | 98 |
|
MVZ Dr. Eberhard & Partner Dortmund Germany | 2 | 1 |
|
MVZ Dr. Eberhard & Partner Dortmund Germany | 2 | 1 |
|
Fulgent Genetics United States | 3 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.